Manufacturing Update: March 2026

Overview

Manufacturing M&A activity has moderated from 2022 peak levels as buyers recalibrate valuations amid mixed macro conditions, shifting trade policies, and evolving financing markets. Despite a more selective environment, high-quality, defensible assets continue to attract strong interest from both strategic and financial buyers. As capital markets stabilize and visibility improves, activity is expected to accelerate into 2026, supported by pent-up supply and sustained sponsor appetite for scaled platforms.

Key Takeaways

  • Deal activity has normalized but remains constructive. While overall volume is below prior highs, competitive tension persists for differentiated assets with resilient margins and exposure to automation, reshoring, infrastructure, and energy-transition tailwinds.
  • Strategics are focused on capability expansion and supply chain control. Buyers are leveraging M&A to enhance technology, expand end-market reach, and improve operational resilience amid geopolitical and tariff uncertainty.
  • Private equity remains an active and well-capitalized buyer. Recent multi-billion-dollar platform acquisitions underscore continued sponsor conviction in scalable manufacturing businesses with consolidation runway.
  • Tariff exposure and sourcing concentration are key diligence themes. Assets with diversified supply chains and meaningful U.S. manufacturing footprints are commanding stronger valuations and broader buyer interest.
  • Valuations show resilience in the lower middle market. Larger, higher-quality businesses continue to achieve premium EV/EBITDA multiples, reflecting disciplined but healthy buyer demand for mission-critical and specialized manufacturing platforms.
download full report

Subscribe to Our M&A Reports

Select Manufacturing Experience

SC&H Capital advises Unjury® in Sale to Blueroot Health, a portfolio company of North Castle Partners.
SC&H Capital Advises DuClaw Brewing Company in Sale to River Horse Brewing Company
Shank's Extracts has been acquired by Universal Corporation
view all transactions

About SC&H Capital

SC&H Capital is an investment banking advisory firm focused on middle-market and growth companies. We combine deep industry experience with a thoughtful, solutions-oriented approach to help founder-owned businesses navigate the M&A process and achieve their strategic objectives.

500+

Transactions Completed

$11B+

in Deal Value Since Inception

35

Seasoned Investment Bankers

Stay Ahead of the Market

Get expert analysis from our Investment Banking team. Download this quarter’s report or subscribe to receive insights straight to your inbox.

SC&H
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.